BLANDINO, Giovanna
 Distribuzione geografica
Continente #
NA - Nord America 6.567
EU - Europa 3.444
AS - Asia 3.014
SA - Sud America 542
AF - Africa 341
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 4
Totale 13.921
Nazione #
US - Stati Uniti d'America 6.282
SG - Singapore 1.603
IT - Italia 1.240
CN - Cina 1.022
UA - Ucraina 794
IE - Irlanda 633
BR - Brasile 471
RU - Federazione Russa 321
CI - Costa d'Avorio 274
CA - Canada 249
VN - Vietnam 136
SE - Svezia 116
GB - Regno Unito 70
DE - Germania 69
FR - Francia 58
KR - Corea 53
IN - India 44
AR - Argentina 27
MX - Messico 26
PL - Polonia 25
SN - Senegal 23
ID - Indonesia 21
CH - Svizzera 20
BD - Bangladesh 18
EC - Ecuador 18
NL - Olanda 18
AT - Austria 17
HK - Hong Kong 16
UZ - Uzbekistan 16
IQ - Iraq 14
ZA - Sudafrica 14
TR - Turchia 13
PK - Pakistan 12
CO - Colombia 11
MA - Marocco 11
CZ - Repubblica Ceca 9
ES - Italia 9
EU - Europa 9
GR - Grecia 9
JP - Giappone 9
BE - Belgio 8
FI - Finlandia 7
LB - Libano 7
EG - Egitto 6
MY - Malesia 6
IR - Iran 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
CL - Cile 4
KE - Kenya 4
LT - Lituania 4
RO - Romania 4
BJ - Benin 3
BO - Bolivia 3
AM - Armenia 2
BB - Barbados 2
BG - Bulgaria 2
BY - Bielorussia 2
DZ - Algeria 2
HN - Honduras 2
IL - Israele 2
MD - Moldavia 2
NO - Norvegia 2
UY - Uruguay 2
AL - Albania 1
AZ - Azerbaigian 1
BS - Bahamas 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
LY - Libia 1
MU - Mauritius 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
RS - Serbia 1
SA - Arabia Saudita 1
TN - Tunisia 1
Totale 13.921
Città #
Dallas 1.138
Santa Clara 848
Singapore 817
Jacksonville 758
Dublin 633
Chandler 578
Boardman 292
Abidjan 274
Nanjing 217
Ashburn 210
Chicago 198
Toronto 181
Lawrence 180
Andover 178
Cambridge 178
Los Angeles 174
Beijing 138
Hefei 138
San Mateo 124
Moscow 103
Wilmington 89
Milan 88
Des Moines 84
Catania 67
Nanchang 61
Shenyang 60
Civitanova Marche 55
Hebei 52
Seoul 52
Jiaxing 51
Rome 49
Ottawa 48
Ho Chi Minh City 47
Saint Petersburg 44
Tianjin 39
Houston 34
Changsha 33
São Paulo 33
Hanoi 29
Bremen 25
Buffalo 25
Dakar 23
Columbus 22
Florence 19
The Dalles 18
Council Bluffs 17
Boston 16
Rio de Janeiro 16
Brooklyn 15
Palermo 15
New York 14
Warsaw 14
Bologna 13
Hangzhou 13
London 13
Atlanta 12
Belo Horizonte 12
Da Nang 12
Norwalk 12
Phoenix 12
Seattle 12
Stockholm 12
Verona 12
Cherasco 11
Hong Kong 11
Pune 11
Turin 11
Ann Arbor 10
Dhaka 10
Genoa 10
Curitiba 9
Jinan 9
Johannesburg 9
Mexico City 9
Angri 8
Brussels 8
Chennai 8
Den Haag 8
Frankfurt Am Main 8
Jakarta 8
Kunming 8
Ribeirão Preto 8
San Francisco 8
Segrate 8
Tokyo 8
Ankara 7
Brasília 7
Grafing 7
Liberty Lake 7
Modena 7
Montreal 7
Mumbai 7
Quito 7
Washington 7
Baghdad 6
Campinas 6
Charlotte 6
Haiphong 6
Leawood 6
Porto Alegre 6
Totale 9.043
Nome #
Caratteristiche di adesione di ceppi di Bifidobacterium lactis BB-12, Bifidobacterium longum W11, Bifidobacterium bifidum su cellule epiteliali umane della linea HT-29 1.006
A novel delta-hemolysis screening method for detecting heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-inermediate S.aureus 143
Antibiotic susceptibility profiles of uncommon bacterial species causing severe infections in Italy 132
3-Methylthio-, 3-(amino-substituted)ethylthio-, 3-carboxymethylthio-, 3,3'-(dithiobis)-5-aryl-4H(R)-1,2,4-triazoles and 2-aminomethyl-N-substituted derivatives of 5-aryl-4H(R)-1,2,4-triazolin-3-thione: synthesis and biological activity 132
Chemical and biological properties of the novel exopolysaccharide produced by a probiotic strain of Bifidobacterium longum 129
Batteri anaerobi non sporigeni. In: MICROBIOLOGIA FARMACEUTICA 125
Impact of gut microbiota on diabetes mellitus 114
Ampliamento dello spettro di attività della vancomicina nei confronti di batteri gram-negativi mediante incapsulazione in liposomi fuso genici 114
CARATTERISTICHE DI ADESIONE DI CEPPI DI BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS BB-12, BIFIDOBACTERIUM LONGUM W11, BIFIDOBACTERIUM BIFIDUM SU CELLULE EPITELIALI UMANE DELLA LINEA HT-29 111
Microbial and clinical effects of systemic flurithromycin therapy in the treatment of periodontal diseases compared with clinical procedures 106
Antibiotic susceptibility of group A streptococci in 2 Italian cities: Milano and Catania 106
Activity of Berberis aetnensis C. Presl. Root extract against Candida strains 104
Antimicrobial susceptibility of Lactobacillus species used in probiotic products 104
Microbial evaluation of "in vitro" antibacterial activity of "one stage full mouth" disinfection with clorexidine in adult periodontitis 102
Antibacterial activity of moxifloxacin against periodontal anaerobic pathogens involved in systemic infections 99
SENSITIVITY TO AUGMENTIN OF ANEROBIC BACTERIA BETA-LACTAMASES PRODUCING. 98
Comparison of systemic flurithromycin therapy and clinical procedures in the treatment of periodontal diseases 98
Antimicrobial susceptibility and Beta-lactamase production of anaerobic and aerobic bacteria isolated from pus specimens from orofacial infections 97
Attività antibatterica di cefprozil nei confronti di Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis e Streptococcus pneumoniae circolanti attualmente in Italia 96
In vitro inhibitory activity of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 alone or in combination against bacterial and Candida reference strains and clinical isolates 96
Antibacterial activity of medicinal plant extracts against periodontopathic bacteria 94
BACTERIOLOGICAL STUDIES OF AMOXYCILLIN-CLAVULANIC ACID AGAINST ANEROBIC BACTERIA. 94
Antimicrobial susceptibility of Lactobacillus species used in probiotic products 93
DIMINUITA PRESENZA DI FATTORI DI VIRULENZA IN ESCHERICHIA COLI UROPATOGENI ANTIBIOTICO-RESISTENTI 92
Bacilli sporigeni aerobi ed anerobi. In: MICROBIOLOGIA FARMACEUTICA 92
Microbiological and clinical periodontal effects of fixed orthodontic appliances in pediatric patients 92
Reactivity of 3-aryl-4-amino-5-mercapto-4H-1,2,4-triazoles: synthesis and biological evaluation of 3,6-diaryl derivatives of 7H-1,2,4-thiazole[3,4-b][1,3,4]thiadiazines, of 3-aryl-4-amino-5-carboxymethylthio-4H-1,2,4-triazoles 91
Growth and adhesion to HT-29 cells inhibition of gram-negatives by Bifidobacterium longum BB536 e Lactobacillus rhamnosus HN001 alone and in combination 91
Bacilli sporigeni aerobi e anaerobi (cap. 37) 91
Synthesis and antimicrobial evaluation of 4-phenyl-3-isoquinolinoyl-hydrazones 90
Studio microbiologico dell’attività antibatterica “in vivo” della disinfezione “one stage full mouth” con clorexidina nella terapia della parodontite dell’adulto 90
Antibiotic prescribing for dental conditions: a community-based study in southern Italy 90
Antimicrobial susceptibility of Lactobacillus strains used in probiotic products 90
Antimicrobial susceptibility of strains of Enterobacteriaceae isolated from bloodstream infections using current CLSI and EUCAST breakpoints 90
Synthesis of 1-aroyl-4H(R)-thiosemicarbazides, the corresponding 5-aryl 4H(R)-1,2,4-triazolin-3-thiones and some derivatives of pharmaceutical interest 89
Meccanismi patogenetici di ceppi di Prevotella intermedia e Fusobacterium nucleatum isolati da parodontopatie e da infezioni polmonari 89
Antibacterial activity and post-antibiotic effect of flurithromycin compared with other macrolides and penicillins against periodontal pathogens 89
Microbiological characteristics of kanendomycin [Caratteristiche microbiologiche della kanendomicina] 88
Effect of a broad-spectrum cephalosporin on the oral and intestinal microflora in patients undergoing colorectal surgery 88
Synthesis and preliminary biological investigation of 2,6-diaryl substituted imidazo(1,2-b)-1,3-4-thiadiazoles [SINTES]I E VALUTAZIONE BIOLOGICA PRELIMINARE DI IMIDAZO[2,1-b]-1,3,4-TIADIAZOLI-2,6-DIARILSOSTITUITI 87
Identification and characterization of Lactobacillus paracasei strain with probiotic properties isolated from faeces of healthy adult volunteers 87
Aztreonam versus gentamicin in short-term prophylaxis in biliary and gastric surgery 87
Antibiotic susceptibility of bacterial isolates from probiotic products available in Italy 87
Dental implants with locking taper connection versus screwed connection: microbiologic and scanning electron microscope study 86
Uso di prebiotici e probiotici ed ecosistema microbico intestinale 86
Colorectal surgery: short-term prophylaxis with clindamycin plus aztreonam or gentamicin 85
Osservatorio Epidemiologico Italiano: analisi del secondo anno di monitoraggio delle resistenze agli antibiotici in Haemophilus influenzae e Haemophilus parainfluenzae 85
Streptococcus pyogenes emm types and subtypes of isolates from paediatric asymptomatic carriers and children with pharyngitis 85
Isolation and characterization of promising probiotic lactobacilli and bifidobacteria from stools of breast-fed infants and honeybees’ gut 85
Comparative in vitro activity of cefodizime and other antibiotics against pathogens recently isolated in Italy 84
Synthesis, spectral behaviour and microbiological properties of some di(nitrothienyl)sulfides. 84
Probiotics:overview of microbiological and immunological characteristics 84
Antimicrobial susceptibility of anaerobic and facultative aerobic bacteria isolated from pus specimens of orofacial infections and beta-lactamase production 84
In vitro activity and clinical efficacy of ciprofloxacin in otorhinolaryngeal infections 83
Study on the adhesion characterstics of Bifidobacterium spp.strains on human epithelial cell line HT-29. 83
Epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains isolated from 2001 to 2005 in Catania 83
Antibacterial activity of moxifloxacin against pathogens related with respiratory tract infections 83
Predictive value of bacterial analysis of laparotomy wounds 83
Antibiotic susceptibility of bacterial isolates from probiotic products available in Italy 83
Complete Genome Sequence of Bifidobacterium longum W11 (LMG P-21586), Used as a Probiotic Strain 83
Intercellular communication during yeast cell growth 82
Osservatorio Epidemiologico Italiano. Patogeni respiratori comunitari e nosocomiali: analisi delle resistenze nel 1997. Haemophilus influenzae, Haemophilus parainfluenzae e Moraxella catarrhalis 82
Incidence of non-fermenting gram-negative bacilli in infected patients 81
SURGICAL SITE INFECTION IN ELDERLY PATIENTS 81
Microbiological intraoperative results in short-term prophylaxis (aztreonam or gentamicin) in abdominal surgery 81
Probiotici e Prebiotici:dalla ricerca al consumatore 81
Bacteriological findings and antimicrobial resistance in odontogenic and non odontogenic chronic maxillary sinusitis 80
Susceptibility of clinical isolates of Haemophilus to new 4-quinolones 79
Caratterizzazione molecolare di ceppi di Lactobacillus spp. utilizzati in prodotti probiotici vaginali e determinazione della sensibilità agli antibiotici 79
Immunomodulatory Effects of Bifidobacterium longum W11 Produced Exopolysaccharide on Cytokine Production 79
Aztreonam versus gentamicin for short-term prophylaxis in biliary and gastric surgery 78
CT findings in hepatic involvement by Echinococcus granulosus 78
PRODUZIONE DI B-LATTAMASI ED ANTIBIOTICO SENSIBILITA’ DI GERMI ANAEROBI. 78
Parodontopatia dell'adulto: 3 terapie a confronto 78
Effetto prebiotico di Opuntia ficus-indica (L.) nei confronti di alcuni ceppi di Lactobacillus e Bifidobacterium isolati da prodotti probiotici farmaceutici 78
Prevenzione e controllo delle infezioni in chirurgia gastrica 77
Studio microbiologico dell'attività "in vivo"della disinfezione "one stage full mouth"con clorexidina nella terapia della parodontite dell'adulto 77
Caratteristiche microbiologiche e terapeutiche dei batteri probiotici 77
Immunizzazione passiva naturale e artificiale. In: MICROBIOLOGIA FARMACEUTICA 77
Correlations between bacterial flora present in the juice and the gastric mucosa and the risk of postoperative infection [Correlazione tra flora batterica presente nel succo e nella mucosa gastrica e rischio di infezione postoperatoria] 76
Evaluation of the antibacterial effect of cefsulodin against Pseudomonadaceae [Valutazione dell'attività antibatterica del cefsulodin nei confronti di Pseudomonadaceae] 76
Bactericidal kinetics and postantibiotic effect of Ciprofloxacin against B. catarrhalis, H. influenzae and S. pneumoniae 75
Impianti dentali a connessione conometrica versus impianti dentali a connessione avvitata:studio microbiologico e al microscopio elettronico a scansione 75
Antimycotic effect of diaryl sulfides with open chains and ring systems containing pyridine and thiadiazole units [Azione antimicotica di alcuni diaril solfuri a catena aperta e ciclici contenenti unità piridiniche e tiadiazoliche] 75
Batteri anaerobi non sporigeni (cap. 38) 75
L'ambiente intestinale e la disbiosi 75
Antimicrobial activity and postantibiotic effect of flurithromycin against Helicobacter pylori strains 75
Virulence factors and antibiotic resistance in uropathogenic Escherichia coli 74
Bactericidal activity and postantibiotic effect of cefdnir (ci 983, fk 482) against selected athogens 74
In vitro activity of imipenem towards gram-negative bacilli 73
Susceptibility of molecularly characterizeted hospital-associated methicillin-resistant Staphylococcus aureus isolates to dalbavancin 73
Microbiological evaluation of 6-beta-amidino-penicillanic acid (mecillinam) 72
Microbiological characteristics of the probiotic strains B. longum BB536 and L. rhamnosus HN001 used in combination 71
Incidence of fermentative and non-fermentative gram-negative bacilli in an intensive care environment [Incidenza di bacilli gram-negativi fermentanti e non fermentanti in ambiente nosocomiale di terapia intensiva] 71
Internalization–associated proteins among Streptococcus pyogenes isolated from asymptomatic carriers and children with pharyngitis 70
Incidence and antibiotic-resistance of gram-negative species isolated from burns [Incidenza antibiotico-resistenza di specie batteriche gram-negative isolate in ustionati] 69
In vitro susceptibility of Arcobacter butzleri and Arcobacter cryaerophilus to different antimicrobial agents 69
Microbiological evaluation of cefoperazone, a new semisynthetic cephalosporin 68
SUSCEPTIBILITY OF CLINICAL ISOLATES OF ENTEROBACTERIACEAE TO CEFDINIR (CI 983, FK 482) 67
Reduced delta-haemolysin activity and agr-expression correlate with an hVISA/VISA phenotype. 66
Totale 9.634
Categoria #
all - tutte 45.272
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.272


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021609 0 0 0 0 0 46 158 15 145 17 173 55
2021/20221.384 197 184 13 33 208 8 200 43 161 3 54 280
2022/20231.919 189 60 26 132 244 344 13 303 511 23 56 18
2023/2024798 49 116 39 66 36 78 29 60 23 48 163 91
2024/20253.144 39 485 200 144 787 269 32 122 248 324 189 305
2025/20263.644 441 398 1.407 386 980 32 0 0 0 0 0 0
Totale 14.168